The role of nitric oxide in arthritic joints: a therapeutic target? pp. 0063 - 0067
K. Nishida, T. Doi, H. Inoue
DOI: 10.1007/s101650050001

Nomenclature and classification of juvenile idiopathic arthritis: where to after Durban pp. 0068 - 0077
P. Manners
DOI: 10.1007/s101650050002

Gene therapy for arthritis pp. 0078 - 0082
H. Kohsaka
DOI: 10.1007/s101650050003

Participation of substance P distribution in the cytokine production of rheumatoid synovium pp. 0083 - 0087
H. Komuro, T. Tanabe, M. Ogushi, et al.
DOI: 10.1007/s101650050004

The relationship between postoperative results and bone dynamics in RA patients who underwent cementless Ortholoc II TKA: histomorphometric study pp. 0088 - 0094
O. Obayashi, S. Sasaki, S. Katsube, et al.
DOI: 10.1007/s101650050005

The expression of matrix metalloproteinases and inhibitors in acute rupture of the anterior cruciate ligament pp. 0095 - 0102
N. Ishiguro, T. Shimizu, T. Ito, et al.
DOI: 10.1007/s101650050006

Additive combination of actarit and methotrexate in the treatment of refractory rheumatoid arthritis pp. 0103 - 0109
M. Aso, Y. Tanaka, K. Saito, et al.
DOI: 10.1007/s101650050007

Sjogren syndrome associated with multiple myeloma of the IgA 3-type pp. 0110 - 0113
T. Akimoto, S. Kobayashi, N. Tamura, et al.
DOI: 10.1007/s101650050008

Dilated cardiomyopathy (DCM) associated with SSA antibody in primary Sjogren syndrome pp. 0114 - 0116
M. Nishinarita, M. Nakagawa, E. Tanaka
DOI: 10.1007/s101650050009

Dermatomyositis and cutaneous necrosis: report of five cases pp. 0117 - 0120
A. Mimori, T. Suzuki, N. Satoh, et al.
DOI: 10.1007/s101650050010